ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0898

A Blood Transcriptome Signature Distinguishes Between Diverse Systemic Autoimmune Diseases and Infection

Kleio-Maria Verrou1, Argyrios Theophilopoulos2, Nikolaos Vlachogiannis3, George Kollias4, Christoforos Nikolaou5 and Petros Sfikakis1, 1Joint Academic Rheumatology Program, School of Medicine, National and Kapodistrian University of Athens. Centre of New Biotechnologies and Precision Medicine (CNBPM), School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, Athens, Greece, 2Department of Immunology, Scripps Clinic and Research Foundation, San Diego, CA, 3Joint Academic Rheumatology Program, School of Medicine, National and Kapodistrian University of Athens. Centre of New Biotechnologies and Precision Medicine (CNBPM), School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, Zografou, Greece, 4Centre of New Biotechnologies and Precision Medicine (CNBPM), School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. Institute for Bioinnovation, Biomedical Sciences Research Center “Alexander Fleming”, Vari, Greece. Department of Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece, Athens, Greece, 5Institute for Bioinnovation, Biomedical Sciences Research Center “Alexander Fleming”, Athens, Greece

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, Bioinformatics, Biomarkers, Gene Expression, Infection

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Genetics, Genomics & Proteomics Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: The most pathogenic responses against self and foreign antigens that lead to systemic autoimmune diseases and infections, respectively, overall engage similar immunologic components. Consequently, there are no molecular markers that distinguish between anti-self and anti-foreign responses. Our aim was to test the hypothesis that whole blood RNA sequencing may distinguish between diverse systemic autoimmune diseases and various infections.

Methods: For comparison we used consecutive peripheral blood RNA sequencing data from the Gene Expression Omnibus database published until December 2021, encompassing 584 patients with various systemic autoimmune diseases and 615 patients with viral, bacterial and parasitic infections.

Results: Data were used as input to our novel state-of-the-art preprocessing pipeline based on gene read counts ranking. With this and additional Machine Learning approaches, we created a model that discriminates between the two groups of pathologies with 98% accuracy. This high discriminating capacity was externally validated in additional datasets comprising of samples not included in the models’ training.
Further analyses using the most informative gene expression profiles revealed that ‘autophagy’, ‘DNA damage response’, ‘RAP-1 signalling’ and ‘NOTCH signalling’ were among the top discriminating pathways. 
Moreover, we identified a set of 24 genes, including the autoimmunity related RPL7, TLK2 and ANK2, whose relative RNA expression levels specifically distinguish between systemic autoimmunity and infection with 88% accuracy.

Conclusion: RNA expression levels of specific genes in peripheral blood distinguish between anti-self and anti-foreign responses, thereby providing a biomarker for the differential diagnosis of the corresponding pathologies in patients presenting with an inflammatory disorder. In addition, this analysis may provide new mechanistic understanding of the systemic autoimmune response.


Disclosures: K. Verrou: None; A. Theophilopoulos: None; N. Vlachogiannis: None; G. Kollias: None; C. Nikolaou: None; P. Sfikakis: None.

To cite this abstract in AMA style:

Verrou K, Theophilopoulos A, Vlachogiannis N, Kollias G, Nikolaou C, Sfikakis P. A Blood Transcriptome Signature Distinguishes Between Diverse Systemic Autoimmune Diseases and Infection [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/a-blood-transcriptome-signature-distinguishes-between-diverse-systemic-autoimmune-diseases-and-infection/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-blood-transcriptome-signature-distinguishes-between-diverse-systemic-autoimmune-diseases-and-infection/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology